For Institutions
GMP Products & Services
Research-Grade Products & Services
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
日本語
简体中文
Menu
For Institutions
GMP Products & Services
Research-Grade Products & Services
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
日本語
简体中文
For Institutions
GMP Products & Services
Research-Grade Products & Services
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
日本語
简体中文
For Institutions
GMP Products & Services
Research-Grade Products & Services
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
日本語
简体中文
Icon-twitter-x
Facebook-f
News
All
Press
Media
Events
Other
[Summary of research available] Kyoto University developed a scalable method to regenerate T-cells from iPSCs
•
February 5, 2021
•
Other
Renewal of I Peace website
•
February 5, 2021
•
Other
I Peace in the News – the NIKKAN KOGYO SHIMBUN December 28, 2020
•
January 10, 2021
•
Media
I Peace, Inc. and Avery Therapeutics announce collaboration to bring iPSC derived cell therapy for heart failure to the clinic
•
December 29, 2020
•
Press
I Peace, Inc. obtains IRB Approval for Production of Clinical and Research-Grade iPSCs for Commercial Use
•
December 4, 2020
•
Press
I Peace CEO Koji Tanabe to Present at 2020 Virtual Cell & Gene Meeting on the Mesa
•
October 7, 2020
•
Events
I Peace CEO Koji Tanabe participates as a speaker in the the International Industrial Fair 2020 Kobe
•
September 5, 2020
•
Events
I Peace in the News – the Nikkei July 28, 2020
•
July 30, 2020
•
Media
Stem Cells for Everyone: Revolutionizing Regenerative Medicine with Mass Manufacturing of Induced Pluripotent Stem Cells (iPSCs)
•
July 15, 2020
•
Press
CEO Tanabe was featured as a speaker at Blockbuster TOKYO 2020’s 3rd Training Program
•
July 8, 2020
•
Events
Reach out to us to learn more
Contact Us